GN in Ten

Duración total:6 h 53 min

	BRB 8: Secondary FSGS	GN in Ten	17:50
	Board Review Bonus 7: Membranous Nephropathy	GN in Ten	24:57
	Board Review Bonus 6: Alport Syndrome	GN in Ten	16:12
	Board Review Bonus 5: Renal Amyloidosis	GN in Ten	19:43
	Episode 12: NephMadness Special! IgAN (Again?!): New B-Cell Targets vs. Complement Inhibitors	GN in Ten	21:27
	Episode 11: Nephmadness Special! Matt Sparks and Aarushi Varshney on C3G	GN in Ten	23:29
	Board Review Basics #4: ANCA Vasculitis	GN in Ten	21:13
	Episode 10: Louise Oni and Jun Oh	GN in Ten	26:04
	Board Review Bonus #3: Lupus Nephritis	GN in Ten	24:41
	Episode 9: Carla Nester on C3 Glomerulopathy and Complement-Mediated Diseases	GN in Ten	21:38
	Episode 8: NephMadness 2025 Genetics Region	GN in Ten	25:12
	Board Review Bonus #2: Minimal Change Disease	GN in Ten	24:56
	Board Review Bonus #1: IgA Nephropathy	GN in Ten	27:49
	Episode 7: Felicitas Hengel and Nicola Tomas on a New Chapter in Anti-Nephrin Autoantibodies	GN in Ten	16:15
	Episode 6: Astrid Weins on Anti-Nephrin Antibodies and Nephropathology	GN in Ten	17:23
	Episode 5: Industry Perspective with Jula Inrig: Endothelin Antagonism, IgAN, FSGS, Clinical Trial Career Paths, and the New Era of Nephrology Trials	GN in Ten	24:54
	Episode 4: NephMadness Special! Anna Burgner on Preeclampsia	GN in Ten	20:01
	Episode 3: Opeyemi Olabisi on APOL1-Mediated Kidney Disease and Community Engagement	GN in Ten	15:28
	Episode 2: Kidney Week Micro-Interviews	GN in Ten	10:51
	Episode 1: Tobias Huber on ISGD and the Future of Glomerular Medicine	GN in Ten	10:46
	Welcome to GN in Ten!	GN in Ten	02:27